Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
Gene: Cmtm2a (CKLF-like MARVEL transmembrane domain containing 2A) Rattus norvegicus
Analyze
Symbol: Cmtm2a
Name: CKLF-like MARVEL transmembrane domain containing 2A
Description: Predicted to have transcription corepressor activity. Predicted to be involved in negative regulation of transcription, DNA-templated and regulation of testosterone biosynthetic process. Predicted to localize to the cytoplasm; integral component of membrane; and nucleus. Orthologous to human CMTM2 (CKLF like MARVEL transmembrane domain containing 2); INTERACTS WITH bisphenol A; ochratoxin A; testosterone enanthate.
Type: protein-coding
RefSeq Status: PROVISIONAL
Also known as: chemokine-like factor super family 1; CKLF-like MARVEL transmembrane domain-containing protein 2A; Cklfsf1; LOC307616
Orthologs:
Latest Assembly: Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Rnor_6.019880,024 - 887,144 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_5.019878,307 - 885,427 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.419629,381 - 636,501 (+)NCBIRGSC3.4rn4RGSC3.4
RGSC_v3.119629,380 - 636,501 (+)NCBI
Celera19667,618 - 674,738 (+)NCBICelera
Cytogenetic Map19p14NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations
Gene-Chemical Interaction Annotations
Gene Ontology Annotations
References - curated
References - uncurated

Genomics

Comparative Map Data
Position Markers
QTLs in Region (Rnor_6.0)
miRNA Target Status

Sequence

Nucleotide Sequences
Protein Sequences
Transcriptome
Promoters

Strain Variation

Strain Sequence Variants (Rnor 5.0)

Additional Information

External Database Links
Nomenclature History
 
More on Cmtm2a
Alliance Gene
NCBI Gene
Ensembl Gene
JBrowse: rn5 rn6
NCBI Genome Data Viewer

RGD Object Information
RGD ID: 1307501
Created: 2005-01-12
Species: Rattus norvegicus
Last Modified: 2019-08-20
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.